Dr. Imel’s clinical and research focus is on bone and mineral disorders, especially rare bone disorders, including X-linked hypophosphatemia (XLH), other hypophosphatemic disorders and rare metabolic bone disorders.
He conducts clinical and translational research in both rare and common musculoskeletal diseases, including clinical trials in X-linked hypophosphatemia (XLH), autosomal dominant hypophosphatemic rickets (ADHR), autosomal dominant osteopetrosis (ADO2), as well as osteoporosis, and studies of musculoskeletal complications of chronic conditions. Dr. Imel also conducts research in congenital adrenal hyperplasia and musculoskeletal complications of cystic fibrosis.
His clinical practice includes care of adult and pediatric patients with metabolic bone disorders, including a large population of children and adults with XLH.
Clinical Interests: Adult and pediatric patients with metabolic bone disorders, including a large population of children and adults with X-linked hypophosphatemia (XLH) and other phosphate disorders, as well as osteogenesis imperfecta and other rare bone diseases. He also sees young adult patients that have transitioned from pediatric to adult care with conditions such as Turner syndrome and classic congenital adrenal hyperplasia.
Subject areas:
- Pediatric Musculoskeletal Disease
-
- Precision Medicine
